Financial distress, psychological distress, and cost-related nonadherence among diabetic patients: Latent profile analysis
Keywords:
cost-related nonadherence, diabetes, financial distress, psychological distress, VietnamAbstract
Background: Diabetes imposes a huge economic burden on individuals, their families, the national health system, and the economy as a whole. Research on financial distress has not yet been explored in the diabetic population in Vietnam. This study was conducted to determine the prevalence of financial distress and its associated demographic, psychological distress, and cost-related nonadherence factors in patients with diabetes.
Methods: A cross-sectional study was conducted on 311 patients with diabetes attending the outpatient department of a public hospital in An Giang, Vietnam, from April 2025 to May 2025. Newly diagnosed, controlled, and ongoing-therapy patients were included and classified by current management into lifestyle modification, oral medications, or insulin therapy (alone or in combination). Latent Profile Analysis (LPA) was performed to classify patients with diabetes into their most likely group based on their financial distress profile.
Results: LPA identified three latent profiles: none (13.5%), mild (56.3%), and moderate (30.2%) financial distress. The ROC analysis identified a score of 25.5 as the optimal threshold for distinguishing between none and mild/moderate financial distress, with a sensitivity of 100% and a specificity of 98.9%. Multinomial logistic regression analysis revealed that higher psychological distress, being a worker or public employee, and cost-related nonadherence were significantly associated with having mild or moderate financial distress.
Conclusion: Psychological distress and cost-related nonadherence are factors influencing financial distress in patients with diabetes. Future interventions should target these factors to help reduce the level of financial distress in this population.
References
1. National Statistics Office. Statistical yearbook of Vietnam. Hanoi: National Statistics Office; 2024.
2. The National Assembly. Law No. 15/2023/QH15 on medical examination and treatment. Hanoi: The National Assembly; 2023.
3. International Trade Administration (ITA). Vietnam - Healthcare. ITA; 2024. Available from: https://www.trade.gov/country-commercial-guides/vietnam-healthcare [Last accessed: 2025 Nov 1].
4. Viet Nam Social Security (VNSS). Universal Health Insurance – A Chance for Equal Access to Healthcare Services. VNSS; 2025. Available from: https://vss.gov.vn/english/news/Pages/vietnam-social-security.aspx?CateID=198&ItemID=12528 [Last accessed: 2025 Nov 1].
5. Butt MD, Ong SC, Rafiq A, Kalam MN, Sajjad A, Abdullah M, et al. A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries. J Pharm Policy Pract. 2024 Apr 19;17(1):2322107. doi: 10.1080/20523211.2024.2322107. PMID: 38650677.
6. Seuring T, Archangelidi O, Suhrcke M. The Economic Costs of Type 2 Diabetes: A Global Systematic Review. Pharmacoeconomics. 2015 Aug;33(8):811–31. doi: 10.1007/s40273-015-0268-9. PMID: 25787932.
7. Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care. 2024 Jan 1;47(1):26–43. doi: 10.2337/dci23-0085. PMID: 37909353.
8. International Diabetes Federation (IDF). Health Expenditure per Person with Diabetes. IDF; 2024. Available from: https://diabetesatlas.org/data-by-indicator/diabetes-related-health-expenditure/diabetes-related-health-expenditure-per-person-id [Last accessed: 2025 Jul 4].
9. International Diabetes Federation (IDF). Viet Nam Diabetes Statistics & Insights. IDF; 2022. Available from: https://diabetesatlas.org/data-by-location/country/viet-nam [Last accessed 2025 Jul 4].
10. National Statistics Office (NSO). Socio-economic situation in the fourth quarter and 2024 – National Statistics Office of Vietnam. NSO; 2024. Available from: https://www.nso.gov.vn/en/highlight/2025/02/socio-economic-situation-in-the-fourth-quarter-and-2024 [Last accessed: 2025 July 4].
11. Patel MR. Financial Toxicity in Diabetes: The State of What We Know. Curr Diab Rep. 2025 May 13;25(1):32. doi: 10.1007/s11892-025-01588-0. PMID: 40358737.
12. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay. Patient. 2017 Jun;10(3):295–309. doi: 10.1007/s40271-016-0204-x. PMID: 27798816.
13. Costanza A, Amerio A, Aguglia A, Serafini G, Amore M, Macchiarulo E, et al. From “The Interpersonal Theory of Suicide” to “The Interpersonal Trust”: an unexpected and effective resource to mitigate economic crisis-related suicide risk in times of Covid-19? Acta Biomed. 2021 Oct 1;92(S6):e2021417. doi: 10.23750/abm.v92iS6.12249. PMID: 34739460.
14. Patel MR, Troost JP, Heisler M, Carlozzi NE. Clinically meaningful classes of financial toxicity for patients with diabetes. J Patient Rep Outcomes. 2025 Jan 6;9(1):2. doi: 10.1186/s41687-024-00834-5. PMID: 39762599.
15. Wentzell K, Nagel KE. Financial stress in emerging adults with type 1 diabetes: a mini review integrating lessons from cancer research. Front Clin Diabetes Healthc. 2024 Jan 26;5:1328444. doi: 10.3389/fcdhc.2024.1328444. PMID: 38344219.
16. Tran BT, Tran TT, Dac QAN, Nguyen HL, Nguyen TX, Nguyen NPT, et al. Financial toxicity in patients with cancer: a cross-sectional study at an oncology hospital in central Vietnam. Support Care Cancer. 2024 Aug 9;32(9):581. doi: 10.1007/s00520-024-08791-x. PMID: 39120733.
17. Minister of Health (MoH). Decision No. 5481/QĐ-BYT on the promulgation of the professional document “Guidelines for the diagnosis and treatment of type 2 diabetes.” Hanoi: MoH; 2020.
18. Tran BT, Le DD, Nguyen TG, Nguyen MT, Nguyen MH, Dang CK, et al. Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer. PLoS One. 2024 Jun 28;19(6):e0306339. doi: 10.1371/journal.pone.0306339. PMID: 38941304.
19. Patel MR, Zhang G, Heisler M, Song PXK, Piette JD, Shi X, et al. Measurement and Validation of the Comprehensive Score for Financial Toxicity (COST) in a Population with Diabetes. Diabetes Care. 2022 Nov 1;45(11):2535–43. doi: 10.2337/dc22-0494. PMID: 36048837.
20. De Tran V, Nguyen TK, Dewey RS, Le MH, Pham DT. Depression, anxiety, and psychological distress in Vietnamese pharmacy and non‐pharmacy students during COVID‐19 pandemic. J Am Coll Clin Pharm. 2023 Mar;6(3):267–75. doi: 10.1002/jac5.1745.
21. De Tran V, Nguyen MC, Nguyen THY, Tran TT, Dewey RS. Cost-related medication nonadherence in the Mekong Delta, Vietnam. Int J Pharm Pract. 2025 February 7;33(1):64–72. doi: 10.1093/ijpp/riae065. PMID: 39657163.
22. Zhang X, Zhang L, Geng Z, Shang M, Wang A, Zheng X, et al. Potential profile analysis of financial toxicity and its related factors among lung cancer patients. BMC Cancer. 2025 Apr 21;25(1):740. doi: 10.1186/s12885-025-14076-1. PMID: 40259218.
23. Esselen KM, Gompers A, Hacker MR, Bouberhan S, Shea M, Summerlin SS, et al. Evaluating meaningful levels of financial toxicity in gynecologic cancers. Int J Gynecol Cancer. 2021 Jun;31(6):801–6. doi: 10.1136/ijgc-2021-002475. PMID: 33858954.
24. Su M, Liu S, Liu L, Wang F, Lao J, Sun X. Heterogeneity of financial toxicity and associated risk factors for older cancer survivors in China. iScience. 2023 Aug 29;26(10):107768. doi: 10.1016/j.isci.2023.107768. PMID: 37731611.
25. Xiaoxuan L, Shuo Z, Shanshan L, Mengxia Y, Tianying Y, Yuxin S, et al. Predictors of Financial Toxicity Trajectories in Patients With Pancreatic Cancer: A Latent Class Growth Analysis. Cancer Med. 2025 May;14(9):e70875. doi: 10.1002/cam4.70875. PMID: 40320835.
26. Kim S, Perry LM, Mossman B, Dunn A, Hoerger M. Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure. PLoS One. 2024;19(7):e0306620. doi: 10.1371/journal.pone.0306620. PMID: 38968278.
27. Kieu TTM, Trinh HN, Pham HTK, Nguyen TB, Ng JYS. Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey. BMJ Open. 2020 Mar 3;10(3):e032303. doi: 10.1136/bmjopen-2019-032303. PMID: 32132135.
28. Cai J. A robust health system to achieve universal health coverage in Vietnam. Lancet Reg Health West Pac. 2023 Jul;37:100854. doi: 10.1016/j.lanwpc.2023.100854. PMID: 37693876.
29. Donkor A, Atuwo-Ampoh VD, Yakanu F, Torgbenu E, Ameyaw EK, Kitson-Mills D, et al. Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis. Support Care Cancer. 2022 Sep;30(9):7159–90. doi: 10.1007/s00520-022-07044-z. PMID: 35467118.
30. Xu B, Hu L, Cheng Q, K W So W. A systematic review of financial toxicity among cancer patients in China. Asia Pac J Oncol Nurs. 2022 Apr;9(8):100071. doi: 10.1016/j.apjon.2022.04.010. PMID: 35692729.
31. Himmelstein DU, Dickman SL, McCormick D, Bor DH, Gaffney A, Woolhandler S. Prevalence and Risk Factors for Medical Debt and Subsequent Changes in Social Determinants of Health in the US. JAMA Netw Open. 2022 Sep 1;5(9):e2231898. doi: 10.1001/jamanetworkopen.2022.31898. PMID: 36112374.
32. Weinick RM, Byron SC, Bierman AS. Who can’t pay for health care? J Gen Intern Med. 2005 Jun;20(6):504–9. doi: 10.1111/j.1525-1497.2005.0087.x. PMID: 15987324.
33. Bui TD, Doan TTD, Giang LT, Glinskaya EE, Karacsony SI, Nga TN, et al. Strengthening Government Stewardship for a Diversified and Resilient Aged Care System in Vietnam - Technical Report and a Case Study of Two Localities: Quang Nam Province and Can Tho City. Washington, DC: World Bank Group; 2022. Available from: http://documents.worldbank.org/curated/en/099000305132220937.
34. Teerawichitchainan B, Knodel J, Loi VM, Huy VT. Gender Division of Household Labor in Vietnam: Cohort Trends and Regional Variations. J Comp Fam Stud. 2010;41(1):57–85. doi: 10.2307/41604338.
35. Ha NN. Household Budget Management and Decision-Making in the Family in the Red River Delta, Vietnam. Vietnam J Fam Gend Stud. 2019;14(2):17–29. https://ifgs.vass.gov.vn/Uploads/files/TapChi/2019/2019-eng/2019-eng-no%202/Bai%202%20Ngo%20Ngan%20Ha%2017-29.pdf
36. Lago-Hernandez C, Nguyen NH, Khera R, Loomba R, Asrani SK, Singh S. Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases. Mayo Clin Proc. 2021 Oct;96(10):2639–50. doi: 10.1016/j.mayocp.2021.02.026. PMID: 34120754.
37. Xia T, Qiu H, Yu B, Bi J, Gu X, Wang S, et al. Cost–related medication nonadherence in US adults with asthma. Ann Allergy Asthma Immunol. 2023 Nov;131(5):606-613.e5. doi: 10.1016/j.anai.2023.07.013. PMID: 37499864.
38. Xu L, Dong Q, Jin A, Zeng S, Wang K, Yang X, et al. Experience of financial toxicity and coping strategies in young and middle-aged patients with stroke: a qualitative study. BMC Health Serv Res. 2024 Jan 17;24(1):94. doi: 10.1186/s12913-023-10457-z. PMID: 38233772.
39. Lin X, Teng X, Lan J, Lu L, Pan Q, Ren Z. Financial toxicity and its influencing factors in young and middle-aged cancer patients: a latent profile analysis. Support Care Cancer. 2025 Apr 28;33(5):427. doi: 10.1007/s00520-025-09485-8. PMID: 40293598.
40. Kim YC, Um YH, Kim SM, Kim TW, Seo HJ, Hong SC, et al. Suicide Risk in Patients With Diabetes Varies by the Duration of Diabetes: The Korea National Health and Nutrition Examination Survey (2019). Psychiatry Investig. 2022 Apr;19(4):326–32. doi: 10.30773/pi.2021.0396. PMID: 35500906.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Minh Hoang Le, Tran Nhat Phong Dao, Phi Phung Hoang, Thanh Binh Trieu, Valeria Valeryevna Dorofeeva, Van De Tran (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.